Metraipolis › archive › dc_ac7fab7d12ff
New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions — Europe PMC PMID:41822268
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41822268
- DOI
- 10.3389/fgstr.2025.1645459
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:57:23.454Z
- SHA-256 of the archived text
db271108ab429fa9f8b235691ffe5edd0955b3f80042b35bd4e03d294d3642d3- Stable URL of this page
https://metraipolis.com/documento/dc_ac7fab7d12ff
How to cite
New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions — Europe PMC PMID:41822268 — Europe PMC (en), https://europepmc.org/article/MED/41822268 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ac7fab7d12ff (Metraipolis archive dc_ac7fab7d12ff, sha256 db271108ab429fa9f8b235691ffe5edd0955b3f80042b35bd4e03d294d3642d3)
BibTeX
@misc{dcac7fab7d12ff,
title = {New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions — Europe PMC PMID:41822268},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41822268},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ac7fab7d12ff; sha256 db271108ab429fa9f8b235691ffe5edd0955b3f80042b35bd4e03d294d3642d3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822268. Agents can read the archived copy with the MCP tool read_document.